| Title: |
Multinational Cost-Consequence Analysis of a Bone Conduction Hearing Implant System-A Randomized Trial of a Conventional vs. a Less Invasive Treatment With New Abutment Technology |
| Authors: |
Van Hoof, Marc; Marco Algarra, Jaime; Joore, Manuela A. |
| Source: |
Van Hoof, Marc Marco Algarra, Jaime Joore, Manuela A. 2020 Multinational Cost-Consequence Analysis of a Bone Conduction Hearing Implant System-A Randomized Trial of a Conventional vs. a Less Invasive Treatment With New Abutment Technology Frontiers In Neurology 11 |
| Publication Year: |
2026 |
| Collection: |
Universitat de València: Roderic - Repositorio de contenido libre |
| Subject Terms: |
cirurgia; oïda; ossos |
| Description: |
Background: It is hypothesized that, for patients with hearing loss, surgically placing an implant/abutment combination whilst leaving the subcutaneous tissues intact will improve cosmetic and clinical results, increase quality of life (QoL) for the patient, and reduce medical costs. Here, incremental costs and consequences associated with soft tissue preservation surgery with a hydroxyapatite (HA)-coated abutment (test) were compared with the conventional approach, soft tissue reduction surgery with an alltitanium abutment (control). Methods: A cost-consequence analysis was performed based on data gathered over a period of 3 years in an open randomized (1:1) controlled trial (RCT) running in four European countries (The Netherlands, Spain, France, and Sweden). Subjects with conductive or mixed hearing loss or single-sided sensorineural deafness were included. Results: During the first year, in the Netherlands (NL), France (FR), and Spain (ES) a net cost saving was achieved in favor of the test intervention because of a lower cost associated with surgery time and adverse event treatments [NL ¿86 (CI −50.33; 219.20), FR ¿134 (CI −3.63; 261.30), ES ¿178 (CI 34.12; 97.48)]. In Sweden (SE), the HA-coated abutment was more expensive than the conventional abutment, which neutralized the cost savings and led to a negative cost (SE ¿-29 CI −160.27; 97.48) of the new treatment modality. After 3 years, the mean cost saving reduced to ¿17 (CI −191.80; 213.30) in the Netherlands, in Spain to ¿84.50 (CI −117.90; 289.50), and in France to ¿80 (CI −99.40; 248.50). The mean additional cost in Sweden increased to ¿-116 (CI −326.90; 68.10). The consequences in terms of the subjective audiological benefit and Health-related quality of life (HRQoL) were comparable between treatments. A trend was identified for favorable results in the test group for some consequences and statistical significance is achieved for the cosmetic outcome as assessed by the clinician. Conclusions: From this multinational cost-consequence analysis it can ... |
| Document Type: |
article in journal/newspaper |
| File Description: |
application/pdf |
| Language: |
English |
| Relation: |
Frontiers In Neurology, 2020, vol. 11; https://hdl.handle.net/10550/121144; 145873 |
| DOI: |
10.3389/fneur.2020.00106 |
| Availability: |
https://hdl.handle.net/10550/121144; https://doi.org/10.3389/fneur.2020.00106 |
| Rights: |
open access |
| Accession Number: |
edsbas.D259E39C |
| Database: |
BASE |